CELL AND GENE OUTSOURCING
Get To Know Minaris Advanced Therapies Testing Services
Learn how we can help you move your pipeline forward, whether you manufacture with us at Minaris Advanced Therapies, in-house, or with one of our fellow CDMOs.
Optimization-By-Design — A Critical Factor In Viral Vector Scale Up
Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.
How To Apply Quality By Design Principles To Cell And Gene Therapy Release Testing
Review how to develop and use QC assays that can facilitate both product and process understanding and control.
Managing Risks In Injectable Drug Delivery
Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.
Mastering The Journey From Initial Method Transfer To Successful Lot Release For Cell & Gene Therapies
View the webinar and learn how efficient project management and optimized communication are cornerstones of a successful transfer process.
Combining An MVA Technology Platform With Innovative Analytical Methods
Learn how this process development platform for MVA impacts vaccine manufacturing and supports the drug life cycle from process and analytical development through trials and commercialization.
Secure And Industrialize Your CGT Process Towards cGMP Manufacturing
Learn the principles of commercialization readiness and guidance to address them in process development as well as the best time to implement automation and minimize commercialization risks.
Critical Supply Chain And Logistics Considerations For Cell And Gene Therapy Management
Explore the unique challenges and complexities involved in key CGT logistics areas like donor and patient accessibility, critical raw materials management, and innovative temperature control equipment.
Viral Vector Manufacturing: Improve Efficiency With A Platform Approach
Learn more about the platform-based scalable suspension process for LVV production and how it is impacting CGTs advancing toward commercialization.
Revolutionizing How Medicines Are Made, Funded, And Scaled
Hear from site leaders and virtually tour the process and analytical development laboratory and GMP manufacturing facility which includes four additional 2,000L single-use bioreactors.
De-Risk Your Path To Clinic With An AAV Suspension Platform
Build a reliable, de-risked path to the clinic while avoiding unforeseen costs and compliance-related delays with advice from Suparna Sanyal, PhD, Head of Viral Vectors Commercial Development.
Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics
In recent years, the number of biotherapeutic molecules requiring more complex assemblies has greatly increased. Typically, these multi-chain molecules are no longer compatible with platform approaches and require a more agile approach to early developability and method d...
Preparing For FDA Pre-Approval Inspection: Quality And Regulatory Topics
Consider these strategies for meeting quality and regulatory requirements in cell and gene therapies that can also help to identify issues early, reduce risks, and prevent delays and rework.
CRISPR Genome Editing Solutions From Discovery To Clinic
Examine how a partnership leveraging expertise in production for high-quality CRISPR gRNAs as well as cGMP manufacturing is supporting the clinical translation of CRISPR genome editing technologies.
From Platform To Patient: Streamlining Gene Therapy Development
Explore how platform processes advance gene therapies, the impact of strong partnerships on patient access, and the future shaped by these collaborations.
Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service
The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, deve...
Mastering The Art Of Developing A Successful Bispecific Antibody
Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.
Manufacturing Life-Saving Gene Therapies
Take a look behind the scenes and hear firsthand about the commitment to patients and clients at Andelyn Biosciences.
Advancing Viral Vector Manufacturing: The Importance Of The Cell Line
Explore the pivotal role of cell lines in viral vector manufacturing, a complex, multi-step process that has traditionally been both time-consuming and labor-intensive.
Candidate Screening And Feasibility Studies For Viral Gene Therapies
Create a simple, modular path to cGMP manufacturing that minimizes risk. Explore a strategic approach for early-stage development and how it can propel therapies to the clinic and the market.
Early Preclinical Development: A Successful Transition To cGMP Manufacturing
Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.
Selecting Containers For Sensitive And Costly Cell & Gene Therapies
Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.
Keys To A Successful cGMP Manufacturing Operation Delivering CGTs
Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.
An End-To-End Industrialization Roadmap For Autologous Cell Therapy
Explore specificities and challenges, leveraging automation for scalability with the Cocoon® Platform, and building a vein-to-vein network to achieve ‘just-in-time’ delivery of therapies.
Minaris Advanced Therapies Philadelphia Campus Overview
Our Philadelphia Campus serves as a centralized hub for collaborative efforts, supporting numerous companies throughout the CGT pipeline, from initial research to commercial-scale manufacturing.
Cryopreservation Best Practices For Cell & Gene Therapy Source Material
Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.
Scalable Suspension LVV Production Platforms
Review a scalable suspension-based Lenti production platform using a proprietary HEK293T clonal cell line and improvement steps to generate commercially viable therapies from concept to patient.
Improved And Rebalanced Plasmids To Ramp Up Your AAV Productivity
Growth in rAAV-based therapies is creating a need for dramatically increased production. Learn how AAV productivity can be optimized using platform technologies capable of affording significantly higher titers.
Expertise In Commercial Fill-Finish For More Than 30 Years
Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.
Future-Proof Your Aseptic Filling
Using the Cytiva SA25 Aseptic Filling Workcell, a standardized system designed with flexibility built in, ensures that companies can pivot between products quickly and adapt as manufacturing needs change.